SpyGlass Pharma, Inc.
Nasdaq SGP · Irvine, CA
Works in Ophthalmology
SpyGlass Pharma, Inc. is a clinical trial sponsor based in Irvine, CA, listed as Nasdaq SGP. It has 5 active clinical trials with 1,048 planned participants, in Ophthalmology. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq SGP
Fundraising
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about SpyGlass Pharma, Inc
SpyGlass Pharma, Inc is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 1,048 planned participants, in Ophthalmology. Since 2021 it has completed 1 trial and stopped 0 early.
SpyGlass Pharma, Inc is based in Irvine, CA and is listed as Nasdaq SGP. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with SpyGlass Pharma, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-06-11.
Approve Suite is not affiliated with SpyGlass Pharma, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.